U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H6ClNO
Molecular Weight 179.603
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLOXYQUIN

SMILES

OC1=CC=C(Cl)C2=C1N=CC=C2

InChI

InChIKey=CTQMJYWDVABFRZ-UHFFFAOYSA-N
InChI=1S/C9H6ClNO/c10-7-3-4-8(12)9-6(7)2-1-5-11-9/h1-5,12H

HIDE SMILES / InChI

Molecular Formula C9H6ClNO
Molecular Weight 179.603
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created based on several sources, including http://www.ncbi.nlm.nih.gov/pubmed/24513205

Cloxyquin has being shown to be a novel activator of the two-pore domain potassium channel TRESK, which is linked to causing migraines and controls the sensitivity of pain nerves in the brain.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: UNIPROT: Q208C2 (Acyl-CoA-binding protein)
0.097 µM [IC50]
3.8 µM [EC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
5 % multiple, topical
Studied dose
Dose: 5 %
Route: topical
Route: multiple
Dose: 5 %
Sources:
unhealthy, 68 years
n = 1
Health Status: unhealthy
Condition: cutaneous mycosis
Age Group: 68 years
Sex: F
Population Size: 1
Sources:
Other AEs: Contact dermatitis...
Other AEs:
Contact dermatitis
Sources:
AEs

AEs

AESignificanceDosePopulation
Contact dermatitis
5 % multiple, topical
Studied dose
Dose: 5 %
Route: topical
Route: multiple
Dose: 5 %
Sources:
unhealthy, 68 years
n = 1
Health Status: unhealthy
Condition: cutaneous mycosis
Age Group: 68 years
Sex: F
Population Size: 1
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer
Tox targets

Tox targets

TargetModalityActivityMetaboliteClinical evidence
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis.
2007 Mar
Bis(μ-5-chloro-quinolin-8-olato)-κN,O:O;κO:N,O-bis-[(acetato-κO,O')lead(II)].
2009 Feb 11
5-Chloro-8-hydroxy-quinolinium nitrate.
2009 May 29
Grafting aluminum(III) 8-hydroxyquinoline derivatives on MCM-41 mesoporous silica for tuning of the light emitting color.
2010 Jun 15
Fragment-based discovery of 8-hydroxyquinoline inhibitors of the HIV-1 integrase-lens epithelium-derived growth factor/p75 (IN-LEDGF/p75) interaction.
2013 Mar 28
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Curator's Comment: Growth of the organisms was determined after reincubation at 37°C for 16 to 24 h by visual determination of a color change from blue to pink. The MIC was defined as the lowest concentration which prevented the color change.
The MICs of cloxyquin for 150 clinical isolates of Mycobacterium tuberculosis ranged from 0.062 to 0.25 g/ml. The MIC50 and MIC90 were 0.125 and 0.25 g/ml, respectively.
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:15:26 GMT 2023
Edited
by admin
on Fri Dec 15 15:15:26 GMT 2023
Record UNII
BPF36H1G6S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLOXYQUIN
MI   USAN  
USAN  
Official Name English
5-CHLORO-8-HYDROXYQUINOLINE
Systematic Name English
NSC-35083
Code English
8-QUINOLINOL, 5-CHLORO-
Systematic Name English
CLOXYQUIN [USAN]
Common Name English
Cloxiquine [WHO-DD]
Common Name English
CLOXIQUINE
INN   MART.   WHO-DD  
INN  
Official Name English
cloxiquine [INN]
Common Name English
CLOXIQUINE [MART.]
Common Name English
CLOXYQUIN [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C254
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID4045973
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
FDA UNII
BPF36H1G6S
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
ECHA (EC/EINECS)
204-978-1
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
NCI_THESAURUS
C61689
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
ChEMBL
CHEMBL225164
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
SMS_ID
100000084038
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
INN
3428
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
CAS
130-16-5
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
EVMPD
SUB06784MIG
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
DRUG CENTRAL
3114
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
PUBCHEM
2817
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
MERCK INDEX
m3675
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY Merck Index
NSC
35083
Created by admin on Fri Dec 15 15:15:26 GMT 2023 , Edited by admin on Fri Dec 15 15:15:26 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY